Diphtheria tetanus inactivated poliovirus vaccine(sanofi pasteur)

白喉破伤风脊髓灰质炎灭活疫苗(赛诺菲巴斯德）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiphtheria tetanus inactivated poliovirus vaccine(sanofi pasteur)
Drug Alias NameIPOLIMOVAX POLOREVAXIS爱宝惟IMOVAX POLIO
ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitis
Global Approved IndicationsPoliomyelitis
Approved Indications in ChinaPoliomyelitis
Original Approved Country/TerritoryUnited States
Original Approved Date1990/12/21
Country/TerritoryUnited StatesPhilippinesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur
Inactive CompaniesN/A
Active IndicationsPoliomyelitis
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA01
Related LinksN/A